Form 4: Inhibrx Biosciences Director Kimberly Manhard Acquires 10,000 Shares

Director Kimberly Manhard purchased 10,000 shares of Inhibrx Biosciences (INBX) at an average price of $13.98 on August 28, 2024.

Summary

• On August 28, 2024, Kimberly Manhard, a director of Inhibrx Biosciences, Inc. (INBX), acquired 10,000 shares of common stock.
• The shares were purchased at a weighted-average price of $13.98, with individual transactions ranging from $13.925 to $14.04.
• Following the transaction, Manhard directly owns 0 shares and indirectly owns 10,000 shares through the Kimberly Joan Manhard Revocable Trust, Dtd 6/4/2012, of which she is a trustee.

Sentiment

Score: 6

Explanation: A director purchasing shares is generally a positive sign, but the impact is limited as it's a relatively small transaction. The sentiment is neutral to slightly positive.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors for signals about management's view of the company's value.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates